Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 215 | 97 | 231 | 403 | 325 |
| Operating Income | -215 | -97 | -231 | -403 | -325 |
| Other Income | -1 | 0 | 0 | 252 | 255 |
| Pre-tax Income | -216 | -97 | -231 | -151 | -69 |
| Income Tax | -1 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -215 | -97 | -231 | -151 | -69 |
| Net Income | $-216 | $-97 | $-231 | $-151 | $-69 |
| EPS Basic Total Ops | -0.40 | 0.00 | -0.40 | 2.40 | N/A |
| EPS Basic Continuous Ops | -0.31 | -0.14 | -0.33 | 30.42 | N/A |
| EPS Diluted Total Ops | -0.40 | 0.00 | -0.40 | 2.40 | N/A |
| EPS Diluted Continuous Ops | -0.31 | -0.14 | -0.33 | 30.42 | N/A |
| EBITDA(a) | $-215 | $-97 | $-231 | $-403 | $-325 |